Page 7 - Journal of Structural Heart Disease Volume 1, Issue 4

Meeting Abstracts
Journal of Structural Heart Disease, December 2015, Volume 1, Issue 4: 152-154
DOI: http://dx.doi.org/10.12945/j.jshd.2015.900-15
CSI Africa 2015 Abstracts
Catheter Interventions in Congenital, Structural and Valvar Heart Disease
http://www.csi-congress.org/africa
Published online: December 2015
USING AMPLATZER OCCLUDERS (ASO, VSD) FOR CLOSING NON-ATRIAL AND NON-VENTRICULAR SEPTAL DEFECTS
Abdurashid Mussayev1, Serik Alimbaev1, Saule Kadirova2, Marat Aripov1 Pya Yuriy Vladimirovich1, Abikeeva Lazzat Sagadatovna1
1 National Research Cardiac Surgery Center; Interventional; Cardiology,
2 Jsc “National Scienti c Center of Cardiac Surgery”; Cardiac Surgery; Interventional
Background: Interventions in a large variety of congenital heart de- fects may require improvisation. In our cases, we used a variety of devices for o -label purposes.
Objective: To study possibility of using Amplatzer Occluders (ASO, VSD) for closing non atrial and ventricular septal defects in 2 patients with CHD and 1 patient after knife injury.
Methods: The rst patient, 11 years old, had an aorto-pulmonary win- dow (APW). Diameter of APW was 8mm, and there was LAA 2015
pulmonary hypertension. The second patient had a communication between right pulmonary artery (PA) and left atrium. The non- inva- sive saturation was 74% and the mean pressure in PA was 7mm Hg. The third patient, 23 years old, had post-traumatic aneurysm of su- prarenal part of abdominal aorta. The ostium of aneurysm was 7mm.
Results: In the rst case, APW was closed by Amplatzer Septal Occlud- er (ASO) of 10mm diameter. There was minimal shunt through the occluder. After 1 month, there was no shunt. In the second case, com- munication was closed with Amplatzer VSD 10mm device. Saturation after closing the communication was 97% and the mean pressure in PA was 9mm Hg. In the third case, ostium of aneurysm was closed with a 10mm ASO.
TRANS-CORONARY ABLATION OF SEPTAL HYPER- TROPHY (TASH) IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM): ACUTE AND LONG-TERM SAFETY AND EFFICACY OUT-COME FROM A SINGLE CENTEREXPERIENCE
Afrah Haroon1, Alfazir Omer2, Rosli Ali2
1 National Cardiothoracic Centre-Alshab Teaching Hospital; Interventional; Adult Cardiology; Khartoum, Sudan 2 National Heart Institute; Interventional; Adult Cardiology; Kuala Lumpur, Malaysia,
Background: Trans-coronary ablation of septal hypertrophy (TASH) has been shown to reduce out ow obstruction and symptom relief in the short and intermediate period.
Objectives: The aim is to assess the long-term e cacy and safety of TASH in a single center experience.
Method: 33 patients were analyzed with symptomatic HOCM, who underwent TASH procedure between 2005- 2014. Procedural success was de ned as improvement in patient symptoms and reduction of the left ventricular (LV) out ow tract pressure gradient by ≥ 50% on echocardiography.
Result: The mean age was 49.4 ± 11.4 years. The mean duration of follow-up was 3.6 ± 2.4 years. The number of septal branches ablated was one in 66.7%, and mean alcohol volume was 3.1 ± 1.8 ml. LVOT gradient reduction was achieved in 91% of patients immediately, with mean gradient reduction from 83 ± 37 mmHg to 42 ± 34mmHg. Most patients, (81.8%) showed clinical improvement in New York Heart As- sociation class. 11 patients developed transient complete heart block and permanent pacemaker was required in one. There was signi cant improvement in severity of mitral regurgitation and inter-ventricular septum thickness with preserved LV function. All p value <0.05.
Conclusion: TASH is a safe and e ective procedure in achieving im- mediate and signi cant long-term reduction in LVOT pressure gradi- ent in symptomatic patient, as well as echocardiographic variables.
Fax +1 203 785 3346
E-Mail: jshd@scienceinternational.org http://structuralheartdisease.org/
© 2015 Journal of Structural Heart Disease Published by Science International Corp. ISSN 2326-4004
Accessible online at:
http://structuralheartdisease.org/